Login| Sign Up| Help| Contact|

Patent Searching and Data


Matches 451 - 500 out of 2,193

Document Document Title
JP5059996B2  
JP2012526052A
The present invention relates to substitution aromatic compounds of formula I, and those pharmacological use. A specific mode of the present invention is a (i) blood obstacle, a (ii) renal damage, 腎症, or renal damage complications, (...  
JP5055185B2  
JPWO2010116990A1
式[1]で表されることを特徴とするケージ −1,2,3,4−シクロペンタンテトラカ ルボン酸−1,3:2,4−二無水物化合物 、およびこれをジアミンと縮合させて得...  
JPWO2010116990A
Cage *1 characterized by what is denoted by a formula [1], 2, 3, 4* cyclopentane tetracarboxylic acid *1, 3:2, a 4* 2 anhydride compound, and the polyimide produced by making condense this with Gia Min. While there is no absorption in an...  
JP5044947B2  
JP5043685B2  
JP5047441B2  
JP5038392B2  
JP5040005B2
There are provided a novel norbornene derivative which is a material for a chemically amplifying type photoresist for F2 laser, possesses excellent transparency and improved dry etching resistivity and has a fluorine-containing ketone un...  
JPWO2010095604A
Alicyclic tetracarboxylic acid manufacturing processes, such as bicyclo [3.3. 0] octane *2* exo*4* exo*6* end *8* end * tetracarboxylic acid of high purity which has high productivity, are provided. A manufacturing method of the alicycli...  
JPWO2010095604A1
高い生産性を有する高純度のビシクロ[3. 3.0]オクタン−2−エキソ−4−エキソ −6−エンド−8−エンド−テトラカルボン 酸などの脂環式テトラカルボン酸製造法...  
JP2012153721A
To provide a substance for the preparation of a medicament of non-insulin dependent diabetes mellitus, hypertension and/or metabolic syndrome.The substance includes the chemical structures of bicyclo[3.2.1]octane or the chemical structur...  
JP5003231B2  
JP2012144514A
To provide a methylenebisdehydroabietic acid which is originated from natural material and can be a starting material of polyester and polyamide, to provide a mixture of regioisomers of dehydroabietic acid derivatives and to provide a me...  
JP2012515776A
The present invention provides the hydroxamic acid compound denoted by general formula (I). P, Z, and m express the same meaning as the inside of this specification among a formula. The present invention indicates the method of dealing w...  
JP4973304B2  
JP2012126689A
To provide a method for producing a fluorinated adamantane derivative which is useful as a synthetic intermediate of medicine and agricultural chemical.The method for producing the fluorinated adamantane derivative represented by formula...  
JP4961689B2  
JP4954417B2  
JP2008530180A5  
JP4944344B2
The invention relates to a novel process for the preparation of certain cyclopropyl carboxylic acid esters and other cyclopropyl carboxylic acid derivatives; a novel process for the preparation of dimethylsulfoxonium methylide and dimeth...  
JP4944440B2  
JPWO2010067824A1
活性化血液凝固第X因子の阻害作用を示し、 血栓性疾患の予防剤および/または治療剤と して有用な化合物の中間体を工業的に製造す る方法の提供が求められていた。本発明...  
JPWO2010067824A
Inhibitory action of the Xth factor of activation blood coagulation was shown, and offer of a method which manufactures industrially an intermediate of a compound useful as a prevention agent and/or a medical treatment agent of a thrombo...  
JP2012051820A
To provide a novel optical resolving agent comprising an optically active azulene derivative which facilitates separation in column chromatography by observation with the naked eye, and a novel method for producing optically active alcoh...  
JP4898079B2  
JP2012503595A
There is provided novel compounds capable of modulating the G-protein-coupled receptor GPR40, compositions comprising the compounds, and methods for their use for controlling insulin levels in vivo and for the treatment of conditions suc...  
JPWO2010010869A1
芳香族ポリカルボン酸の芳香環を、ロジウム 、および、パラジウム及び/又は白金をカー ボン担体に担持した触媒存在下で水素化して 芳香族ポリカルボン酸の水素化物を製造...  
JPWO2010010869A
How to hydrogenate the aromatic ring of aromatic polycarboxylic acid under the catalyst existence which supported rhodium and palladium, and/or platinum to the carbon carrier, and to manufacture the hydrogenation thing of aromatic polyca...  
JP2011530608A
The present invention provides synthetic routes for preparing various isomers of cyclohexane-based coolants, such as menthyl esters and menthanecarboxamide derivatives, in particular those substituted at the amide nitrogen, for example w...  
JP2004538252A5  
JP2011241161A
To provide a production method by which 2,3,5-tricarboxycyclopentylacetic acid of a production precursor of 2,3,5-tricarboxycyclopentylacetic acid-1,4:2,3-dianhydride can be produced in high purity under a mild condition by using inexpen...  
JP2011236229A
To provide use of certain cyclopropyl carboxylic acid esters in a process for the preparation of intermediates that can be used in the synthesis of pharmaceutically active entities, and to provide the intermediates provided by these proc...  
JP2011528358A
This application is a formula:(I) [the inside of a formula, T, W, X, Y, Z, and R1R2R4And R6the modulator of MCP*1 of] defined as a は detailed in the letter, its stereoisomeric form, a prodrug, or the salt permitted in medicine or CCR*2...  
JP4796607B2
In the presence of an imide compound (e.g., N-hydroxyphthalimide) shown by the formula (2): wherein R<1> and R<2> independently represents a hydrogen atom, a halogen atom, an alkyl group, an aryl group, a cycloalkyl group; or R<1> and R<...  
JP4788068B2  
JP4777970B2  
JP4769346B2  
JP2011524399A
The present invention relates to a process for the preparation of 1-(2-ethyl-butyl)-cyclohexanecarboxylic acid which is useful as an intermediate in the preparation of pharmaceutically active compounds.  
JP2011523953A
The invention relates to a process for preparing a compound according to formula (I) The invention also relates to intermediates useful in the process.  
JP4742210B2  
JP4742239B2  
JP2011521980A
Disclosed is a process for preparing isopimaric acid, comprising the following steps: First step: dissolving thermally isomerized rosin in acetone, adding in drops a solution of isobutanolamine in acetone to form a precipitate, standing,...  
JP4725136B2  
JP4725137B2  
JP2011516448T
A manufacturing method of the compound shown by formula (I) useful as an intermediate in manufacture of a medicine active compound.  
JP2011516447A
i. a. the manufacturing method of the compound shown by a formula (Ia) useful as an intermediate in manufacture of a medicine active compound.  
JP2011516447T
i. a. the manufacturing method of the compound shown by a formula (Ia) useful as an intermediate in manufacture of a medicine active compound.  
JP2011516448A
A process for the preparation of a compound of formula (I): which are useful as intermediates in the preparation of i.a. pharmaceutically active compounds.  

Matches 451 - 500 out of 2,193